Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Steris Corp (STE) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 5,900,880
  • Shares Outstanding, K 86,150
  • Annual Sales, $ 2,239 M
  • Annual Income, $ 111 M
  • 36-Month Beta 1.27
  • Price/Sales 2.64
  • Price/Book 1.98

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.09 +3.89%
on 01/03/17
70.51 -1.15%
on 01/19/17
+0.79 (+1.15%)
since 12/19/16
3-Month
63.80 +9.25%
on 11/04/16
70.51 -1.15%
on 01/19/17
+0.70 (+1.01%)
since 10/19/16
52-Week
61.38 +13.55%
on 02/12/16
74.63 -6.61%
on 09/22/16
+2.62 (+3.91%)
since 01/19/16

Most Recent Stories

More News
Les C. Vinney Named 2016 NACD Top 100 Directors

The National Association of Corporate Directors (NACD) has named SPR(R) Therapeutics' Board Member, Les C. Vinney, one of the top 100 most influential people in the boardroom and corporate governance community...

The Zacks Analyst Blog Highlights: Wells Fargo, Danaher, Colgate-Palmolive, STERIS and Aetna

The Zacks Analyst Blog Highlights: Wells Fargo, Danaher, Colgate-Palmolive, STERIS and Aetna

Top Research Reports for December 29, 2016

Top Research Reports for December 29, 2016

Research Reports Initiation on Medical Equipment Stocks -- Lantheus, Nevro, Steris, and Spectranetics

Ahead of today's session, Stock-Callers.com presents these four equities in the Medical Appliances and Equipment space for review: Lantheus Holdings Inc. (NASDAQ: LNTH), Nevro Corp. (NYSE: NVRO), Steris...

Steris Poor Q2 Disappoints, Synergy Health Raises Hope

On Dec 7, we issued an updated research report on OH-based STERIS plc (STE).

MedTech Sails Through Macro Woes: Stocks in Focus

MedTech Sails Through Macro Woes: Stocks in Focus

STERIS (STE): Q2 Results Disappoint, Acquisitions Bode Well

On Nov 23, we issued an updated research report on OH-based STERIS plc (STE).

Technical Reports on Medical Equipment Equities -- Lantheus, Nevro, Steris, and Spectranetics

Stock-Callers.com redirects investors' attention to the Medical Appliances and Equipment industry which is engaged in the manufacture of medical instruments such as dental and surgical appliances. Companies...

Steris (STE) Misses on Q2 Earnings and Sales, Cuts View

Steris Plc (STE) reported second-quarter fiscal 2017 adjusted earnings per share (EPS) of 89 cents, missed the Zacks Consensus Estimate by a penny.

STERIS plc Announces Financial Results for Fiscal 2017 Second Quarter

- Second quarter revenue growth of 32%

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company's operating segments consists of Healthcare, Life Sciences and STERIS...

See More

Support & Resistance

2nd Resistance Point 70.57
1st Resistance Point 70.31
Last Price 69.77
1st Support Level 69.66
2nd Support Level 69.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.